Welgene Biotech Co.,Ltd. (TPEX:6661)

Welgene Biotech Revenue

Welgene Biotech had revenue of 83.77M TWD in the quarter ending March 31, 2026, with 7.54% growth. This brings the company's revenue in the last twelve months to 381.82M, up 15.00% year-over-year. In the year 2025, Welgene Biotech had annual revenue of 375.94M with 16.55% growth.

• Revenue (ttm): 381.82M
• Revenue Growth: +15.00%
• P/S Ratio: 0.98
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 372.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	375.94M	53.39M	16.55%
Dec 31, 2024	322.55M	42.00M	14.97%
Dec 31, 2023	280.55M	-41.35M	-12.85%
Dec 31, 2022	321.90M	9.25M	2.96%
Dec 31, 2021	312.65M	-85.45M	-21.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error